Feline Leukemia Virus: Causes, Symptoms, and Treatment

Understanding Feline Leukemia Virus

Feline leukemia virus (FeLV) is one of the most significant infectious diseases affecting domestic cats worldwide. This gammaretrovirus was first identified in 1964 and remains a leading infectious cause of disease and death in cats globally. FeLV is a retrovirus that specifically targets the feline immune system, progressively weakening it and making infected cats susceptible to a wide range of secondary infections and diseases. Unlike some viral infections, feline leukemia cannot be transmitted to humans or other non-feline pets, making it a species-specific concern for cat owners.

The virus primarily affects young cats and kittens, as their immune systems are still developing and lack the maturity to mount an effective immune response. However, cats of any age can become infected with FeLV, and the outcomes vary considerably depending on the individual cat’s immune competence and the specific viral strain involved.

How Feline Leukemia is Transmitted

Understanding transmission routes is crucial for preventing FeLV infection in at-risk cat populations. The virus spreads through multiple pathways, and awareness of these transmission methods can help cat owners implement effective preventive measures.

Primary Transmission Routes

FeLV is primarily transmitted through direct contact with infected saliva, making it a virus that spreads easily among cats living in close quarters. Common transmission scenarios include grooming, licking, biting, or sharing food and water bowls. Cats may also acquire the infection through oronasal contact with infectious saliva or urine, which represents the most likely mode of horizontal transmission between cats. Bite wounds from infected cats are a less common but still significant source of transmission.

Vertical and Other Transmission Routes

Mother cats can transmit FeLV to their kittens through transplacental infection during pregnancy, during the birthing process, or through nursing milk. This vertical transmission is particularly concerning as kittens infected in utero often develop progressive infections with severe disease outcomes. Additionally, FeLV can be transmitted through blood transfusions, making it essential that all blood donors are tested for FeLV provirus using appropriate diagnostic methods.

Other less common sources of viral shedding include nasal secretions, urine, and feces, though tears and feces are not considered clinically important routes for disease transmission or diagnostic detection.

Risk Factors for FeLV Infection

Certain cat populations face significantly higher risks of acquiring FeLV infection. Identifying these risk factors can help cat owners determine whether their pets require vaccination or enhanced preventive measures.

Non-pedigree cats, intact males, and cats living in outdoor or multi-cat household environments (particularly those with five or more cats) face elevated infection risks. Cats from high-prevalence areas and those without FeLV vaccination are particularly vulnerable. Unvaccinated kittens and young cats represent a high-risk group due to their developing immune systems. Additionally, cats with known exposure to FeLV-positive animals or those adopted from shelters or rescue organizations may carry increased infection risk.

Clinical Manifestations and Disease Progression

How FeLV Affects the Body

FeLV adversely affects the cat’s body in multiple ways through its ability to infect a wide range of tissues. The virus can infect bone marrow, salivary glands, gastrointestinal tract, and respiratory epithelium, leading to diverse clinical presentations. One of the most serious consequences is that FeLV is the most common cause of cancer in cats, particularly lymphoma associated with certain viral subgroups. The virus may also cause various blood disorders, including non-regenerative anemia and bone marrow suppression.

Types of FeLV Infection

The outcome of FeLV infection depends on the dynamic interaction between the virus and the cat’s immune system. This balance is particularly critical during the early stages of infection, typically within the first twelve weeks after exposure. Classification of FeLV infection includes four main courses:

Abortive infection: The cat’s immune response prevents provirus integration and viraemia. The cat effectively eliminates the infection.

Regressive infection: This may include transient viraemia, and FeLV integrates into the host’s cell as provirus. The virus can potentially be reactivated if the cat experiences stress or immune compromise.

Progressive infection: Cats show persistent viraemia and viral shedding, subsequently developing FeLV-associated disease.

Focal infection: Rare cases where FeLV is sequestered to certain tissues, also called atypical infection.

Common Clinical Signs

Infected cats may experience a variety of clinical signs depending on the stage and severity of infection. These can include lethargy, loss of appetite, weight loss, and poor coat condition. Lymph node enlargement, fever, and oral disease are also common presentations. As the disease progresses, cats may develop secondary infections, anemia, and cancer-related symptoms requiring urgent veterinary intervention.

FeLV Subgroups and Variants

FeLV exists as multiple subgroups with different characteristics and disease associations. FeLV-A is usually necessary for replication of other subgroups and is the only form naturally transmitted. Effective immunity against FeLV-A protects against all subgroups.

FeLV-B arises through recombination between FeLV-A and endogenous FeLV sequences and is associated with increased risk of lymphoma. It is not naturally transmitted unless co-infected with FeLV-A. Infections with FeLV-B are associated with higher viral loads and more severe disease outcomes.

FeLV-C develops from point mutations in FeLV-A and is strongly linked to non-regenerative anemia. It disrupts the haem transporter receptor, interfering with erythroid maturation and blood cell production. FeLV-D is a rare recombinant form with uncertain infectivity and pathogenicity.

Diagnostic Testing for FeLV

When Testing is Recommended

Testing for FeLV infection is recommended when cats are first acquired, before vaccination against FeLV, and if there has been potential exposure or bite wound from a cat of unknown or positive status. Annual testing is recommended if the cat lives in a household with FeLV-positive cats or cats of unknown status. All cats should be tested before blood donation, and testing is essential if the cat has outdoor access.

Diagnostic Test Methods

Most testing begins in clinic with a point-of-care (POC) ELISA or rapid immunomigration (RIM) FeLV test. These tests detect soluble FeLV antigen as early as 30 days after exposure and have shown good sensitivity and specificity, ranging from 85-100%. The primary tests used are ELISA and IFA (Immunofluorescence Assay). ELISA tests detect early infection, while IFA tests confirm persistent infection.

For more detailed classification, quantitative real-time PCR assay can distinguish between regressively and progressively FeLV-infected cats. Cats with less than 1 million proviral DNA copies/mL are more likely to be regressively infected, while those with 1 million or more copies/mL are more likely to be progressively infected. Positive results may require confirmation through follow-up testing after 8-12 weeks to differentiate between infection types.

Pre-vaccination testing is critical, as cats should be screened for FeLV antigenemia and ideally also provirus to avoid vaccinating already infected cats, as vaccination provides no benefit to infected animals.

Prevention Through Vaccination

Vaccination Recommendations

All at-risk cats should be vaccinated against FeLV. The vaccination protocol begins with the first dose administered at 8-9 weeks of age, followed by a second dose at 12 weeks. This primary series provides essential protection during the critical early life period when kittens are most vulnerable to infection.

Pre-Vaccination Testing

Before vaccination, cats should be screened for FeLV antigenemia to avoid vaccinating already infected cats. Testing for both antigen and provirus is ideal for comprehensive assessment. Vaccinating an infected cat provides no benefit and may complicate disease management.

Treatment and Management Strategies

Treatment Approaches

While there is no cure for FeLV, prevention through vaccination and managing exposure risk is crucial. Treatment focuses on supportive care, including regular veterinary check-ups, prompt treatment of secondary infections, and maintaining good nutrition. Early detection and aggressive treatment of secondary infections are essential because infected cats’ compromised immune systems make them vulnerable to opportunistic pathogens.

Comprehensive Management for Infected Cats

Physical examinations should be performed semiannually, focusing on external parasites, skin infections, dental disease, lymph node size, and body weight. Routine fecal testing, complete blood count (CBC), serum biochemical analysis, and urinalysis should be conducted regularly. All infected cats should be neutered to prevent viral transmission through breeding.

Owners should be advised to watch for clinical signs of FeLV-related disease, particularly secondary infections. Although FeLV-positive cats often respond well to treatment, management requires careful attention and prompt intervention when complications arise.

Living with Feline Leukemia

The prognosis for FeLV-infected cats varies considerably. If a cat becomes infected with FeLV, the disease is very often fatal as there is no cure to date. In fact, up to 90% of infected cats will die within four years of diagnosis. However, some cats may survive longer with appropriate supportive care and management of secondary infections.

Infected cats should be isolated from other cats to prevent transmission. They require regular veterinary monitoring, prompt treatment of any secondary infections, and supportive care to maintain quality of life. Many infected cats can enjoy reasonable quality of life for extended periods with attentive care and management.

Frequently Asked Questions

Q: Can humans contract feline leukemia from infected cats?

A: No, feline leukemia virus cannot be transmitted to humans. It is a species-specific virus that affects only cats and some wild felids.

Q: How long can a cat live with feline leukemia?

A: While up to 90% of infected cats may die within four years, some cats live longer with appropriate supportive care. The lifespan depends on the infection type, viral load, and quality of management.

Q: Is there a cure for feline leukemia?

A: No, there is currently no cure for feline leukemia. Treatment focuses on managing symptoms, preventing secondary infections, and maintaining quality of life.

Q: Should FeLV-positive and FeLV-negative cats be separated?

A: Yes, infected cats should be isolated from uninfected cats to prevent transmission, particularly if the uninfected cats are unvaccinated.

Q: Can indoor cats get feline leukemia?

A: While indoor cats have lower risk, they can still contract FeLV through contact with infected cats, contaminated items, or if they have outdoor access.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete